Skip to main content
Fig. 4 | BMC Medical Genomics

Fig. 4

From: High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis

Fig. 4

Knockdown of SRSF9 inhibits the proliferation and migration of HCC cells. A Overall survival of patients with HCC with high and low expression of SRSF9 based on TCGA database; B–C Viability of shRNA-treated cells at each assay time point; D, E Positive staining of Ki67 in different treatment groups; F colony staining results for HCC cells treated with shRNA. G Staining results for migrated cells from different treatment groups. *P < 0.05, **P < 0.01, ***P < 0.001 versus shNC group

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us